Heart transplantation and left ventricular assist device therapy: Two comparable options in end-stage heart failure?

Clinical Cardiology

Volumn 36, Issue 7, 2013, Pages 378-382

  Garbade, Jens ^a   Barten, Markus J ^a   Bittner, Hartmuth B ^a,b   Mohr, Friedrich Wilhelm ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FLORIDA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOSPORIN A; WARFARIN;

BLOOD FLOW; CARDIAC GRAFT REJECTION; CLINICAL EFFECTIVENESS; DONOR; HEALTH CARE QUALITY; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; LIVER FUNCTION; OVERALL SURVIVAL; PUMP; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; TECHNOLOGY; TREATMENT OUTCOME;

HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; PROSTHESIS DESIGN; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; WAITING LISTS;

EID: 84879842353     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22124     Document Type: Review

References (29)

1. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant. 2010; 29: 1089-1103.
2. Francis GS, Greenberg BH, Hsu DT, et al. ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical competence statement on management of patients with advanced heart failure and cardiac transplant. J Am Coll Cardiol. 2010; 56: 424-453.
3. German organ transplantation fondation (DSO); http://www.dso.de/uploads/ tx-dsodl/dso-jb2011-e-www.pdf.
4. Kirklin JK, Naftel DC, Kormos RL, et al. Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011; 30: 115-123.
5. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001; 345: 1435-1443.
6. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007; 357: 885-896.
7. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009; 54: 312-321.
8. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361: 2241-2251.
9. Aggarwal S, Pagani FD,. Bridge to transplantation: current outcomes. J Card Surg. 2010; 25: 455-461.
10. Lietz K, Miller LW,. Patient selection for left-ventricular assist devices. Curr Opin Cardiol. 2009; 24: 246-251.
11. Wilson SR, Mudge GH, Stewart GC, et al. Evaluation for a ventricular assist device. Circulation. 2009; 119: 2225-2232.
12. Warner Stevenson L, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009; 28: 535-541.
13. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010; 29: S1-S39.
14. Rogers JG, Aaronson KD, Boyle AD, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advance heart failure patients. J Am Coll Cardiol. 2010; 55: 1826-1834.
15. Hunt SA,. Taking heart-cardiac transplantation past, present, and future. N Engl J Med. 2006; 355: 231-235.
16. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011. J Heart Lung Transplant. 2011; 30: 1078-1094.
17. Komoda T, Hetzer R, Lehmkuhl HB,. Influence of new Eurotransplant heart allocation policy on outcome of heart transplant candidates in Germany. J Heart Lung Transplant. 2008; 27: 1108-1114.
18. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011; 10; 57: 1890-1898.
19. Gregoric ID, Cohn WE, Frazier OH,. Diaphragmatic implantation of the HeartWare ventricular assist device. J Heart Lung Transplant. 2011; 30: 467-470.
20. Griffith BP, Kormos RL, Borovetz HS, et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg. 2001; 71 (3 suppl): S116-S120.
21. Cheung A, Lamarche Y, Kaan A, et al. Off-pump implantation of the HeartWare HVAD Left Ventricular Assist Device through minimally invasive incisions. Ann Thorac Surg. 2011; 91: 1294-1296.
22. Loforte A, Monica PLD, Montalto A, et al. HeartWare third-generation implantable continuous flow pump as biventricular support: mid-term follow-up. Interact Cardiovasc Thorac Surg. 2011; 12: 458-460.
23. Strueber M, O'Driscoll G, Jansz P, et al.; HeartWare Investigators. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011; 57: 1375-1382.
24. Slaughter MS, Ising MS, Tamez D, et al. Increase in circadian variation after continuous- flow ventricular assist device implantation. J Heart Lung Transplant. 2010; 29: 695-697.
25. Hetzer R, Krabatsch T, Stepanenko A, et al. Long-term biventricular support with the HeartWare implantable continuous flow pump. J Heart Lung Transplant. 2010; 29: 822-824.
26. Strueber M, Meyer AL, Malehsa D, et al. Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg. 2010; 140: 936-937.
27. Loforte A, Montalto A, Monica PLD, et al. Biventricular support with the HeartWare implantable continuous flow pump: an additional contribution. J Heart Lung Transplant. 2010; 29: 1443-1444.
28. Casas F, Reddy SN, Shambaugh C, et al. The MVAD impeller: design elements. ASAIO J. 2011; 57: 81.
29. Lietz K., Destination therapy: patient selection and current outcomes. J Card Surg. 2010; 25: 462-471.